Titre:
  • A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir.
Auteur:Shand, N.; Weber, F; Mariani, Luigi; Bernstein, Mark; Gianella-Borradori, Athos; Long, Z.; Sorensen, AG; Barbier, Nicolas Serge; GLI328 European-canadian study group,
Informations sur la publication:Human gene therapy, 10, 14, page (2325-2335)
Statut de publication:Publié, 1999-09
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Antiviral Agents -- therapeutic use
Brain -- pathology
Brain -- surgery
Brain Neoplasms -- surgery
Brain Neoplasms -- therapy
Combined Modality Therapy
Female
Ganciclovir -- therapeutic use
Gene Therapy
Glioblastoma -- surgery
Glioblastoma -- therapy
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Neoplasm Recurrence, Local
Simplexvirus -- enzymology
Simplexvirus -- genetics
Survival Analysis
Thymidine Kinase -- genetics
Note générale:Clinical Trial
Clinical Trial, Phase I
Clinical Trial, Phase II
Journal Article
Multicenter Study
Langue:Anglais
Identificateurs:urn:issn:1043-0342
info:doi/10.1089/10430349950016979
info:pmid/10515452